clinical trial · NCT07516925
A Study of Ivonescimab in People With Leiomyosarcoma
LeiomyosarcomaIvonescimab
brief summary
The purpose of this study is to find out if Ivonescimab is an effective and safe treatment that causes few or mild side effects for people with advanced/unresectable leiomyosarcoma.
started
Apr 1, 2026
primary completion
Apr 1, 2029
completion
Apr 1, 2029
last updated
Jun 3, 2026
official title
Vonescimab for the Treatment of Previously Treated Advanced or Unresectable Leiomyosarcoma - a Phase II Trial
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol